Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene.
Most papers first2,521 to 2,540 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| IFNA17 interferon alpha 17 | 3451 HGNC:5422 | 1 | 84 | 2 | 10 | 1,175 | 2,506 |
| LIN28B lin-28 RNA binding posttranscriptional regulator B | 389421 HGNC:32207 | 1 | 47 | 0 | 0 | 1,664 | 2,505 |
| RANBP2 RAN binding protein 2 | 5903 HGNC:9848 | 1 | 26 | 0 | 0 | 1,557 | 2,505 |
| POU1F1 POU class 1 homeobox 1 | 5449 HGNC:9210 | 1 | 29 | 0 | 0 | 1,028 | 2,504 |
| CENPF centromere protein F | 1063 HGNC:1857 | 1 | 33 | 0 | 0 | 1,492 | 2,501 |
| PREP prolyl endopeptidase | 5550 HGNC:9358 | 1 | 29 | 0 | 0 | 1,282 | 2,494 |
| MAP2K6 mitogen-activated protein kinase kinase 6 | 5608 HGNC:6846 | 1 | 71 | 0 | 0 | 1,919 | 2,492 |
| ETS2 ETS proto-oncogene 2, transcription factor | 2114 HGNC:3489 | 1 | 47 | 0 | 0 | 1,885 | 2,490 |
| RPA2 replication protein A2 | 6118 HGNC:10290 | 1 | 56 | 0 | 0 | 1,906 | 2,490 |
| USF1 upstream transcription factor 1 | 7391 HGNC:12593 | 1 | 25 | 0 | 0 | 1,889 | 2,490 |
| CBR1 carbonyl reductase 1 | 873 HGNC:1548 | 1 | 42 | 0 | 0 | 1,369 | 2,488 |
| IL17RB interleukin 17 receptor B | 55540 HGNC:18015 | 1 | 307 | 0 | 0 | 1,723 | 2,488 |
| EPHX2 epoxide hydrolase 2 | 2053 HGNC:3402 | 1 | 22 | 2 | 3 | 1,549 | 2,484 |
| LTB lymphotoxin beta | 4050 HGNC:6711 | 1 | 262 | 1 | 8 | 1,907 | 2,481 |
| ADAMTS4 ADAM metallopeptidase with thrombospondin type 1 motif 4 | 9507 HGNC:220 | 1 | 29 | 0 | 0 | 1,059 | 2,479 |
| SERPINB5 serpin family B member 5 | 5268 HGNC:8949 | 1 | 97 | 0 | 0 | 1,207 | 2,479 |
| PSMB8 proteasome 20S subunit beta 8 | 5696 HGNC:9545 | 1 | 82 | 7 | 1,241 | 1,525 | 2,476 |
| ARID1B AT-rich interaction domain 1B | 57492 HGNC:18040 | 1 | 0 | 0 | 0 | 2,129 | 2,473 |
| BDKRB1 bradykinin receptor B1 | 623 HGNC:1029 | 1 | 31 | 3 | 4 | 929 | 2,473 |
| LINC01194 long independently transcribed non-coding RNA 1194 | 404663 HGNC:37171 | 0 | 0 | 0 | 0 | 1,723 | 2,471 |
Code
curl "https://conductscience.org/api/genes/v1?page=127"
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=127
{
"data": {
"total": 193990,
"results": [
{
"id": "3451",
"title": "IFNA17: interferon alpha 17",
"summary": "NCBI Gene 3451. 1 protein, 84 patents, 2 drugs, 10 trials, 1,175 NIH grants and 2,506 papers.",
"record": "/library/genes/3451",
"gene_id": 3451,
"symbol": "IFNA17",
"name": "interferon alpha 17",
"hgnc_id": "HGNC:5422",
"counts": {
"proteins": 1,
"patents": 84,
"drugs": 2,
"trials": 10,
"grants": 1175,
"papers": 2506
}
},
{
"id": "389421",
"title": "LIN28B: lin-28 RNA binding posttranscriptional regulator B",
"summary": "NCBI Gene 389421. 1 protein, 47 patents, 0 drugs, 0 trials, 1,664 NIH grants and 2,505 papers.",
"record": "/library/genes/389421",
"gene_id": 389421,
"symbol": "LIN28B",
"name": "lin-28 RNA binding posttranscriptional regulator B",
"hgnc_id": "HGNC:32207",
"counts": {
"proteins": 1,
"patents": 47,
"drugs": 0,
"trials": 0,
"grants": 1664,
"papers": 2505
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.2.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "No license stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "Public domain (US government)"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubMed",
"license": "NLM's terms",
"notice": null,
"short": "NLM's terms"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=128",
"request_id": "SzjU8ml5MWVC4M-3"
}Ask about these results. The first 10 go in the prompt.
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant